Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window
- 1 December 2015
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 42 (12) , 923-930
Abstract
No abstract availableKeywords
Funding Information
- Ligue Contre le Cancer de Haute Normandie
This publication has 21 references indexed in Scilit:
- FOLFIRI-Bevacizumab As First-Line Chemotherapy in 3500 Patients With Advanced Colorectal Cancer: A Pooled Analysis of 29 Published TrialsClinical Colorectal Cancer, 2013
- Scheduling of Radiation with Angiogenesis Inhibitors Anginex and Avastin Improves Therapeutic Outcome via Vessel NormalizationClinical Cancer Research, 2007
- Pathophysiologic Effects of Vascular-Targeting Agents and the Implications for Combination with Conventional TherapiesCancer Research, 2006
- Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cellsInternational Journal of Cancer, 2005
- ZD6474, a Potent Inhibitor of Vascular Endothelial Growth Factor Signaling, Combined With RadiotherapyClinical Cancer Research, 2004
- Pathophysiological Effects of Vascular Endothelial Growth Factor Receptor-2-Blocking Antibody plus Fractionated Radiotherapy on Murine Mammary TumorsCancer Research, 2004
- Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane GhostsThe American Journal of Pathology, 2004
- Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in TumorsCancer Research, 2004
- Tumor angiogenesis and accessibility: Role of vascular endothelial growth factorSeminars in Oncology, 2002
- Role of integrins in cell invasion and migrationNature Reviews Cancer, 2002